LIZOFIX
MRP: 540
Packaging: 300ml
Pack Type: infusion
Composition:
Linezolid 600mg/300ml
Indication:
Community Acquired Pneumonia, Hospital Acquired Pneumonia, Nosocomial Infections, Diabetic Foot Ulcer, Post Surgical Prophylaxis, SSTI and cSSTI due to MSSA or MRSA.
Description:
Linezolid 600 mg/300 ml is an intravenous antibiotic used to treat serious infections caused by Gram-positive bacteria, including strains resistant to other antibiotics such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). It belongs to the oxazolidinone class and works by inhibiting bacterial protein synthesis, effectively stopping bacterial growth.
Commonly prescribed for complicated skin infections, pneumonia, and bloodstream infections, this IV formulation ensures rapid delivery and high bioavailability.
Tags:
- Effective against multi-drug resistant Gram-positive bacteria
- Rapid IV delivery for severe infections
- Treats pneumonia, complicated skin infections, and bacteremia
- Alternative to vancomycin-resistant infections
Usage Information
Dosage
Usual dose: 600 mg IV every 12 hours Infuse over 30–120 minutes as directed by physician Duration depends on infection severity, typically 10–14 days
Side Effects
Diarrhea, nausea Headache, dizziness Thrombocytopenia (low platelets) Peripheral neuropathy and optic neuropathy with long-term use Serotonin syndrome risk with certain drugs
Contraindications
Hypersensitivity to Linezolid or oxazolidinones Concurrent use of MAO inhibitors or serotonergic drugs without supervision Caution in patients with blood disorders or neuropathy Pregnancy and breastfeeding only if benefits justify risks